Navigation Links
Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO

the 3 patients with ovarian cancer, -- 1 patient (13 prior regimens) who was on study for more than 16 months had a near complete resolution of ascites and left pleural effusion, and an 83% decrease in CA125.

Toxicities were mainly Grade 1 and 2 (diarrhea, fatigue, headache, arthralgia, nausea). One patient with multiple prior trastuzumab and doxorubicin containing regimens experienced a dose-limiting toxicity of hypoxia and left ventricular ejection fraction reduction at 100 mg/m2. Two patients treated at 80 mg/m2 experienced reversible Grade 3 ocular keratitis; following a treatment holiday both patients continued therapy with reduced doses (one patient remains on study).

Data from a separate 13-patient ongoing Phase 1 trial of alvespimycin also administered weekly were presented. These data showed a confirmed partial response in one patient with hormone refractory prostate cancer, who remains on study after 12 months, and prolonged stable disease in 2 patients, including one patient with prostate adenocarcinoma (on study for 22 weeks) and one patient with metastatic melanoma (on study for 15 weeks). There was no dose-limiting or Grade 3 or 4 drug-related toxicity associated with weekly doses of alvespimycin at up to 40 mg/m2. These data were presented by investigators from the United Kingdom on Sunday, June 3, 2007, in a poster titled "A Phase I Trial of the Heat Shock Protein 90 (Hsp90) Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG, Alvespimycin) Administered Weekly)."

Alvespimycin Development Plan

Kosan's Phase 1 trial of alvespimycin in combination with trastuzumab is continuing, with plans to add paclitaxel (Taxol(R)) to the regimen.

Kosan plans to initiate a Phase 2 study of alvespimycin as monotherapy in patients with HER2-positive metastatic breast cancer who have not previously been treated with trastuzumab. This trial will be conducted in Eastern Europe. Kosan anticipat
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
2. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
3. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
4. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:1/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ... stock of Solta Medical, Inc. (NASDAQ: SLTM ...
(Date:1/14/2014)... 14, 2014 HeartWare International, Inc . (NASDAQ: ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... expects revenues for the fourth quarter of 2013 will ... to approximately $208 million. "Our full-year revenue ...
(Date:1/14/2014)... HILLSBORO, Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- ... and a targeting guide with accompanying instrumentation to place ... new adjunct to the soft tissue (e.g. ligament) repair ... soft tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... WASHINGTON, Dec. 6, 2011  BodyMedia, the leading developer ... Qualcomm Life, a wholly owned subsidiary of Qualcomm ... BodyMedia FIT ™ LINK Armband ... BodyMedia Armband users to share wireless health data, ...
... 6, 2011  Echo Therapeutics, Inc. (Nasdaq: ECTE ... a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system ... today announced a registered direct equity financing of approximately ... of one share of its common stock and a ...
Cached Medicine Technology:BodyMedia Plans to Join Qualcomm Life's Wireless Health 2net Ecosystem 2BodyMedia Plans to Join Qualcomm Life's Wireless Health 2net Ecosystem 3BodyMedia Plans to Join Qualcomm Life's Wireless Health 2net Ecosystem 4Echo Therapeutics Announces Pricing of $5.4 Million Registered Direct Equity Financing 2Echo Therapeutics Announces Pricing of $5.4 Million Registered Direct Equity Financing 3
(Date:7/9/2014)... N.Y. Although feelings are personal and subjective, ... code that objectively represents emotions across different senses, ... by Cornell University neuroscientist Adam Anderson. , "We ... the orbitofrontal cortex, an area of the brain ... code which captures an individual,s subjective feeling," says ...
(Date:7/9/2014)... extinctions around the world have been linked to ... research from the National Institute for Mathematical and ... may also contribute. , In a series ... causes severe hemorrhage of internal organs in frogs, ... frogs if they are exposed to the virus ...
(Date:7/9/2014)... the most important organs in the human body. Its ... properly this is its synthesis function and ... this is its detoxification function. Lack of exercise and ... the liver. The resulting diseased cells can lead to ... failure. According to the German Liver Foundation, over five ...
(Date:7/9/2014)... , , , , ... , , , , ... microphone is 50m downrange from the firer and approximately 30cm from the bullet... , , ... , , , , , ... , , , , , , University of ...
(Date:7/8/2014)... and cardiovascular health as other healthy mature individuals, according ... Journal of Transplantation . The findings may provide some ... professionals caring for them. , Over the past two ... and older has become more common. Given the links ... removal of a kidney could make older donors vulnerable ...
Breaking Medicine News(10 mins):Health News:Study cracks how the brain processes emotions 2Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 2Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 3Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 4Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 5Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 6Health News:Fit for the frontline? New study identifies the hearing requirements of British soldiers 7Health News:Study finds kidney donation safe for healthy older adults 2
... ... ... ... ...
... ... ... ... ...
... White ... ... 2010 -- In its latest white paper, Summit Health "draws" upon 10 years of ... for their wellness strategy and workplace culture., , ,The extensive new article is titled ...
... ... Compounds Including 12 Different Iridoids. , ... Provo, UT (Vocus) March 3, 2010 -- Tahitian Noni International (TNI) announced ... new bioactive beverages are Tahitian Noni® Original, Tahitian Noni® Family, Tahitian Noni® Extra, ...
... ... chromium, is present is some dietary supplements, including two popular weight loss supplements, ... were also found in two weight loss products and ConsumerLab.com noted concern for ... No problems were found with 7-keto DHEA supplements. , ...
... ... ... ... ...
Cached Medicine News:Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 2Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 3Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 4Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 5Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 6Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 7Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 8Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 9Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 10Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 11Health News:'Project Runway's' Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style 12Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 2Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 3Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 4Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 5Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 6Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 7Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 8Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 9Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 10Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 11Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 12Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 13Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 14Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 15Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 16Health News:General Nutrition Centers, Inc. Reports Fourth Quarter 2009 Results 17Health News:Blood Draw Dilemma: New Summit Health Article Helps Employers Choose the Best Screening Method 2Health News:Blood Draw Dilemma: New Summit Health Article Helps Employers Choose the Best Screening Method 3Health News:Five New Tahitian Noni Bioactive Beverages™ Announced 2Health News:Five New Tahitian Noni Bioactive Beverages™ Announced 3Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 2Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 3Health News:ConsumerLab.com Finds Carcinogenic form of Chromium in Supplements, Including Those for Weight Loss 4Health News:Air China to Expand Boeing Airplane Health Management Coverage 2
125I radioimmunoassay, Simple extraction procedure, Ready-to-use calibrators, Less than 0.1% crossreactivity with DHEA-SO4, 2-hour single incubation, 37C, Calibration Range: 0.5 30 ng/mL...
Inquire...
EL-RF/3 is for measurement of IgM, IgG, IgA RF with high specificity for rheumatoid arthritis....
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum....
Medicine Products: